Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.51 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.51 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1525623 | 0.98 | ALDH1A1 (0.54) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL7133160 | 0.86 | MAPT (0.49) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL28688295 | 0.85 | KMT2A (0.55) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL11260961 | 0.85 | KMT2A (0.55) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL4711040 | 0.84 | ALDH1A1 (0.51) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL10923842 | 0.84 | ALDH1A1 (0.50) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL20521859 | 0.84 | MEN1 (0.47) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL30581858 | 0.84 | ALDH1A1 (0.51) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL9610136 | 0.84 | ALDH1A1 (0.42) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 | |
| SCHEMBL28068586 | 0.84 | MAPT (0.44) | ALDH1A1HTTKDM4EKMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-220159929-U | Mixing device for preparing 2, 4-dichlorophenylacetic acid methyl ester | 安徽云帆药业有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-116969900-A | Preparation process of 2- (2, 4-dichlorophenyl) -3- (1-H, 1,2, 4-triazolyl) propanol | 安徽云帆药业有限公司 | 2023-10-31 | — | — | CN | claimed |
| CN-219849507-U | Quantitative dosing device for preparing 2, 4-dichlorophenylacetic acid methyl ester | 安徽云帆药业有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-101987854-A | Preparation method of clopidogrel and salts thereof | BEIJING VENTUREPHARM TECHNOLOGY CO LTD | 2011-03-23 | — | — | CN | claimed |
| US-12162882-B2 | Quinolone derivatives as fibroblast growth factor receptor inhibitors | PRINCIPIA BIOPHARMAC, INC. (US) | 2024-12-10 | — | — | US | disclosed |
| CN-118702710-A | Method for synthesizing organoboron compound by visible light catalysis | 常州大学 | 2024-09-27 | — | — | CN | disclosed |
| US-20240092777-A1 | Quinolone Derivatives as Fibroblast Growth Factor Receptor Inhibitors | PRINCIPIA BIOPHARMA INC. (US) | 2024-03-21 | — | — | US | disclosed |
| CN-220159929-U | Mixing device for preparing 2, 4-dichlorophenylacetic acid methyl ester | 安徽云帆药业有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-220159929-U | Mixing device for preparing 2, 4-dichlorophenylacetic acid methyl ester | 安徽云帆药业有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-220159929-U | Mixing device for preparing 2, 4-dichlorophenylacetic acid methyl ester | 安徽云帆药业有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-219996583-U | Sampling detection device in preparation process of 2- (2, 4-dichlorophenyl) methyl acrylate | 安徽云帆药业有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-116969900-A | Preparation process of 2- (2, 4-dichlorophenyl) -3- (1-H, 1,2, 4-triazolyl) propanol | 安徽云帆药业有限公司 | 2023-10-31 | — | — | CN | disclosed |
| WO-2002087573-A1 | CRF RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2002-11-07 | — | — | WO | disclosed |
| WO-2002088095-A1 | FUSED PYRIMIDINES AS ANTAGONISTS OF THE CORTICOTROPIN RELEASING FACTOR (CRF) | GLAXO GROUP LIMITED (GB) | 2002-11-07 | — | — | WO | disclosed |
| EP-1218359-A2 | PIPERAZINE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001025219-A2 | PIPERAZINE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2001-04-12 | — | — | WO | disclosed |
| WO-1996015672-A1 | FUNGICIDAL COMPOSITION | ZENECA LIMITED (GB) | 1996-05-30 | — | — | WO | disclosed |
| WO-1996015671-A1 | HERBICIDES | ZENECA LIMITED (GB) | 1996-05-30 | — | — | WO | disclosed |
| US-4598085-A | Fungicidal 1-(2-aryl-2-R-ethyl)-1H-1,2,4-triazoles | JANSSEN PHARMACEUTICA N.V. (BE) | 1986-07-01 | — | — | US | disclosed |
| EP-0099165-A1 | Triazole and imidazole compounds, process for their preparation and their use as fungicides and plant growth regulators, and intermediates for their synthesis | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12162882-B2 | Quinolone derivatives as fibroblast growth factor receptor inhibitors | FGFR1, FGFR3, FGFR2 | ALDH1A1 1116/4885HTT 3490/4885KDM4E 2775/4885 |
| US-20240092777-A1 | Quinolone Derivatives as Fibroblast Growth Factor Receptor Inhibitors | FGFR1, FGFR3, FGFR2 | ALDH1A1 1116/4885HTT 3490/4885KDM4E 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.